# Occludin and Zonulin in Attention-deficit/Hyperactivity Disorder

> **NCT05502471** · NA · COMPLETED · sponsor: **Ataturk University** · enrollment: 79 (actual)

## Conditions studied

- Attention-deficit/Hyperactivity Disorder

## Interventions

- **DIAGNOSTIC_TEST:** Zonulin
- **DIAGNOSTIC_TEST:** Occludin

## Key facts

- **NCT ID:** NCT05502471
- **Lead sponsor:** Ataturk University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 79 (ACTUAL)
- **Last updated:** 2022-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05502471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05502471, "Occludin and Zonulin in Attention-deficit/Hyperactivity Disorder". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05502471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*